Peter Woolfson

656 total citations
27 papers, 211 citations indexed

About

Peter Woolfson is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Peter Woolfson has authored 27 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Epidemiology. Recurrent topics in Peter Woolfson's work include Lysosomal Storage Disorders Research (17 papers), Glycogen Storage Diseases and Myoclonus (6 papers) and Trypanosoma species research and implications (6 papers). Peter Woolfson is often cited by papers focused on Lysosomal Storage Disorders Research (17 papers), Glycogen Storage Diseases and Myoclonus (6 papers) and Trypanosoma species research and implications (6 papers). Peter Woolfson collaborates with scholars based in United Kingdom, Australia and South Africa. Peter Woolfson's co-authors include Sanjay M Banypersad, Manish Motwani, Stephen Waldek, Ana Jovanović, Raluca B Dumitru, Sven Plein, Dominik Schlosshan, Kuntal Chakravarty, Voon H Ong and Marina Anderson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Peter Woolfson

22 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Woolfson United Kingdom 7 127 96 75 51 49 27 211
Rosaleen Parsons United States 4 305 2.4× 147 1.5× 48 0.6× 106 2.1× 11 0.2× 6 355
Jacobo Villalobos Venezuela 7 251 2.0× 111 1.2× 27 0.4× 51 1.0× 5 0.1× 16 286
Eiji Ehara Japan 9 51 0.4× 86 0.9× 9 0.1× 11 0.2× 92 1.9× 26 265
Ravi Vijapurapu United Kingdom 9 175 1.4× 121 1.3× 4 0.1× 31 0.6× 141 2.9× 27 292
Heidegger Mateos‐Toledo Mexico 9 126 1.0× 165 1.7× 80 1.1× 108 2.1× 11 0.2× 23 335
Eduardo Payá Spain 6 165 1.3× 128 1.3× 11 0.1× 48 0.9× 147 3.0× 13 297
Maurice Willis United States 8 96 0.8× 17 0.2× 10 0.1× 20 0.4× 13 0.3× 21 230
Laure Bottin France 5 9 0.1× 41 0.4× 38 0.5× 27 0.5× 5 0.1× 11 139
Tim Salinger Germany 7 72 0.6× 49 0.5× 3 0.0× 17 0.3× 60 1.2× 14 141
Antonino Oliveri United States 7 25 0.2× 127 1.3× 12 0.2× 5 0.1× 37 0.8× 10 194

Countries citing papers authored by Peter Woolfson

Since Specialization
Citations

This map shows the geographic impact of Peter Woolfson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Woolfson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Woolfson more than expected).

Fields of papers citing papers by Peter Woolfson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Woolfson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Woolfson. The network helps show where Peter Woolfson may publish in the future.

Co-authorship network of co-authors of Peter Woolfson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Woolfson. A scholar is included among the top collaborators of Peter Woolfson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Woolfson. Peter Woolfson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Reena, Simon Jones, Robert Wynn, et al.. (2025). Iron metabolism and hematological abnormalities in adult patients affected with mucopolysaccharidoses. Molecular Genetics and Metabolism Reports. 44. 101243–101243.
2.
McCarron, Éamon P, Andrew Bentley, Peter Woolfson, et al.. (2025). Genetic Insights and Diagnostic Challenges in Highly Attenuated Lysosomal Storage Disorders. Genes. 16(8). 915–915. 1 indexed citations
3.
McCarron, Éamon P, Rajkumar Chinnadurai, Jonathan M. Meyer, et al.. (2025). Real-world clinical outcomes in adult patients with Fabry disease: A 20-year retrospective observational cohort study from a single centre. Molecular Genetics and Metabolism Reports. 43. 101229–101229. 4 indexed citations
4.
Vijapurapu, Ravi, Adrian Warfield, Derralynn Hughes, et al.. (2023). Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease. Open Heart. 10(2). e002316–e002316. 6 indexed citations
5.
Black, Nicholas, Josephine H. Naish, Peter Woolfson, et al.. (2023). Disease-specific therapy for the treatment of the cardiovascular manifestations of Fabry disease: a systematic review. Heart. 110(1). 19–26. 6 indexed citations
6.
Watkins, Amy, Maélène Lohézic, David Clark, et al.. (2023). Inflammatory Fabry Cardiomyopathy Demonstrated Using Simultaneous [18F]-FDG PET-CMR. JACC Case Reports. 15. 101863–101863. 1 indexed citations
7.
Vijapurapu, Ravi, Hibba Kurdi, Peter Woolfson, et al.. (2023). Clinical utilisation of implantable loop recorders in adults with Fabry disease—a multi-centre snapshot study. Frontiers in Cardiovascular Medicine. 10. 1323214–1323214. 1 indexed citations
8.
Bradley, Joshua, Laura Bonnett, Josephine H. Naish, et al.. (2022). Validated Model for Prediction of Adverse Cardiac Outcome in Patients With Fabry Disease. Journal of the American College of Cardiology. 80(10). 982–994. 23 indexed citations
9.
Vijapurapu, Ravi, William Bradlow, Francisco Leyva, et al.. (2022). Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy. Orphanet Journal of Rare Diseases. 17(1). 6–6. 9 indexed citations
10.
Stępień, Karolina M., et al.. (2022). Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention. Frontiers in Cardiovascular Medicine. 9. 851016–851016. 2 indexed citations
11.
12.
Taylor, Michael, Antje Teubner, Arun Abraham, et al.. (2020). Infective Endocarditis in Patients With Intestinal Failure: Experience From a National Referral Center. Journal of Parenteral and Enteral Nutrition. 45(2). 309–317. 1 indexed citations
13.
Stępień, Karolina M., et al.. (2020). Cardiac rhythm abnormalities - An underestimated cardiovascular risk in adult patients with Mucopolysaccharidoses. Molecular Genetics and Metabolism. 130(2). 133–139. 7 indexed citations
14.
Wallace, Andrew J., Heather J. Church, Karen Tylee, et al.. (2020). Mosaic Fabry Disease in a Male Presenting as Hypertrophic Cardiomyopathy. SHILAP Revista de lepidopterología. 11(1). 1–9. 2 indexed citations
15.
16.
Vijapurapu, Ravi, Tarekegn Geberhiwot, Ana Jovanović, et al.. (2019). Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy. Heart. 105(23). 1825–1831. 14 indexed citations
17.
Motwani, Manish, Sanjay M Banypersad, Peter Woolfson, & Stephen Waldek. (2012). Enzyme replacement therapy improves cardiac features and severity of Fabry disease. Molecular Genetics and Metabolism. 107(1-2). 197–202. 41 indexed citations
18.
Caldwell, Jane C., Peter Woolfson, Bernard Clarke, & Clifford J. Garratt. (2011). Ventricular Fibrillation Following Successful DC Cardioversion for Atrial Fibrillation. Pacing and Clinical Electrophysiology. 35(12). e361–4.
19.
Woolfson, Peter, et al.. (2004). Plethysmography without venous occlusion for measuring forearm blood flow: comparison with venous occlusive method. Clinical Physiology and Functional Imaging. 24(5). 296–303. 3 indexed citations
20.
Woolfson, Peter, Brian Pullan, & Philip Lewis. (2003). Blood Flow Measurement From Plethysmographic Pulse Waves Without Venous Occlusion. Biomedical Instrumentation & Technology. 37(1). 41–46. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosaleen Parsons Breakdown of academic impact, for papers by Jacobo Villalobos Breakdown of academic impact, for papers by Eiji Ehara Breakdown of academic impact, for papers by Ravi Vijapurapu Breakdown of academic impact, for papers by Heidegger Mateos‐Toledo Breakdown of academic impact, for papers by Eduardo Payá Breakdown of academic impact, for papers by Maurice Willis Breakdown of academic impact, for papers by Laure Bottin Breakdown of academic impact, for papers by Tim Salinger Breakdown of academic impact, for papers by Antonino Oliveri
Rankless by CCL
2026